[TimAlerts] $PBYI might really take a crap here
[TimAlerts] $PBYI - 95.4% of patients experienced all grade diarrhea ... 39.8% of the patients experienced grade 3 or higher diarrhea, 1 grade 4
[TimAlerts] $PBYI was a great RSI reversal play
[TimAlerts] real crappy news on $PBYI but it recovered nicely
[TimAlerts] Adam Feuerstein @adamfeuerstein now $PBYI RBC’s Simos Simeonidis notes g3 diarrhea rates increased from previous cuts of loperamide prophylaxis data. A “significant negative."
[TimAlerts] Adam Feuerstein @adamfeuerstein now $PBYI is adding budesonide to the anti-diarrheal prophylaxis for neratinib. Signals a potential problem with using just loperamide.
[TimAlerts] https://twitter.com/adamfeuerstein/status/798191847860502529 $PBYI — I’m told the stock is reacting negatively to this neratinib abstract for San Antonio breast cancer mtg —> http://www.abstracts2view.com/sabcs/view.php?nu=SABCS16L_989&terms
[TimAlerts] $PBYI will resume at 10:52:52
[TimAlerts] $PBYI impressive dump
Join now or log in to leave a comment